Thrombospondin-1 serum levels do not correlate with pelvic pain in patients with ovarian endometriosis
- PMID: 19917115
- PMCID: PMC2785805
- DOI: 10.1186/1757-2215-2-18
Thrombospondin-1 serum levels do not correlate with pelvic pain in patients with ovarian endometriosis
Abstract
Objective: Thrombospondin-1 serum levels is correlate with pelvic pain in patients with ovarian endometriosis.
Patients: Thrombospondin-1 serum levels were prospectively analysed in 51 patients (group A asymptomatic patients or patients presenting mild dysmenorrhea and women comprised group B severe dysmenorrhea and/or chronic pelvic pain and/or dyspareunia) who underwent surgery for cystic ovarian endometriosis to asses whether a correlation exists among thrombospondin-1 serum levels and pelvic pain.
Results: From 56 patients, five cases were ultimately excluded, because the histological diagnosis was other than cystic ovarian endometriosis (2 teratomas and 3 haemorrhagic cysts). The mean thrombospondin-1 serum levels in group A was 256,69 pg/ml_+37,07 and in group B was 291,41 pg/ml + 35,59.
Conclusion: Pain symptoms in ovarian endometriosis is not correlated with thrombospondin-1 serum levels.
References
-
- McLaren J. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod. 1996;11:220–223. - PubMed
-
- Ferriani RA, Charnock-Jones DS, Prentice A, Thomas EJ, Smith SK. Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction. Hum Reprod. 1993;8:11–6. - PubMed
LinkOut - more resources
Full Text Sources